Background
==========

The abundance in natural products and drug candidates of saturated five-membered heterocycles, such as tetrahydrofurans and pyrrolidines, makes these motifs attractive targets for synthesis. Over the last decade we have developed a powerful general strategy for the preparation of such compounds based upon the multi-faceted reactivity of the sulfone group and the formally disfavoured 5-*endo*-trig mode of cyclisation. \[[@B1]-[@B6]\] The methodology allows the conversion of epoxides (X = O) or aziridines (X = N-PG) (**2**) into the desired trisubstituted tetrahydrofurans or pyrrolidines (**5**) *via*a series of sulfone-mediated transformations (Scheme [1](#C1){ref-type="fig"}). Ring-opening **2**with the sulfone-stabilised anion of **1**forms the first C-C bond and furnishes **3**. Modification of the work of Julia \[[@B7]-[@B9]\] then utilises the sulfone to facilitate stereocontrolled alkenylation to give the cyclisation substrate **4**. Finally, 5-*endo*-trig cyclisation yields the desired heterocycles **5**. Overall, the sulfone moiety enables two C-C bond forming steps, allows stereocontrol of the alkene and activates the alkene to cyclisation. Furthermore, the sulfone can be used to elaborate the basic framework post-cyclisation.
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In this publication we outline the application of this methodology to the synthesis of the indolizidine, (+)-monomorine I. \[[@B10]-[@B13]\] We have briefly described this work in a previous communication. \[[@B4]\]

Results and Discussion
======================

The pyrrolidine ring is an important structural motif that occurs in a range of pheromones, venoms and drug candidates. \[[@B14]\] In order to demonstrate the synthetic utility of the sulfone-mediated 5-*endo*-trig methodology. \[[@B3]\] we embarked on the total synthesis of the indolizidine alkaloid monomorine I, the trail pheromone of the Pharaoh worker ant *Monomorium pharaonis*. \[[@B10]\] Our initial synthetic plan is outlined in Scheme [2](#C2){ref-type="fig"}; aziridine **6**, prepared from D-norleucine by standard transformations, would be converted into the 2,5-*syn*disubstituted pyrrolidine core **8***via*alkene **7**. With all the required carbon atoms in place, the final steps would involve deprotection, intramolecular hydroamination of the alkene and desulfonylation.
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Initial studies directed towards this goal exploited the tosyl moiety as the nitrogen-protecting group (PG) and resulted in a succinct synthesis of alkenes of the type **4**(X = NTs; Scheme [1](#C1){ref-type="fig"}). \[[@B15]\] Disappointingly, all attempts to ring-close the sulfonamides proved fruitless, and it was found that desulfonylation was necessary before cyclisation could be achieved. Whilst the tosyl-based methodology permitted the synthesis of a range of simple, non-functionalised pyrrolidines **5**(X = NH), the harsh nature of the deprotection reaction, treatment with hydrobromic acid and phenol in acetic acid at reflux, led to the destruction of the the terminal alkene functionality of **7**(PG = Ts; Scheme [2](#C2){ref-type="fig"}) required for our synthesis of (+)-monomorine I. As a result of this set-back, a second nitrogen protecting group was assessed. The diphenylphosphinyl group (PG = P(O)Ph~2~= Dpp) overcame many of the problems encountered with the tosyl group; protected alkenes **4**(X = NDpp) underwent smooth 5-*endo*-trig cyclisation to furnish *N*-(diphenylphosphinyl)pyrrolidines **5**(X = Dpp) in good yields. \[[@B3],[@B16]\] Furthermore, dephosphinylation was readily achieved under either Lewis acidic or Brønsted acid conditions compatible with a range of functional groups. This second-generation methodology was limited by the finding that acylation of **3**(X = NDpp) could only be achieved with non-enolisable acid chlorides, rendering it unsuitable for the synthesis of (+)-monomorine I. Ultimately, no single protecting group was found to be suitable and it was necessary to exploit a combination of protecting groups. The full evolution of the 5-*endo*-trig cyclisation-based pyrrolidine methodology will be described in a future publication.

Key to the successful synthesis of (+)-monomorine I was the use of the *N*-(benzoyl)aminosulfone **11**(Scheme [3](#C3){ref-type="fig"}). Benzamide **11**could be prepared from *N*-(diphenylphosphinyl)aziridine **9**by ring-opening with **1**followed by protecting group interchange. Although this strategy was not as elegant as utilising an *N*-benzoylaziridine directly, we deemed it prudent not to subject such a species to nucleophilic attack due to reported issues with chemoselectivity. \[[@B17]\] Careful optimisation obviated the need for chromatography following the protecting group exchange, and the benzamides **11**could be isolated in high purity and good yield. Hydroxyalkylation with a range of aldehydes proceeded without issue to give the β-hydroxysulfones **12**in excellent yields. The β-hydroxysulfones were then acylated under standard conditions to give **13**. Treatment of the β-acetoxysulfones **13**with two equivalents of base gave the pyrrolidines **14**directly as the product of a one-pot elimination-cyclisation cascade. The pyrrolidines were formed with complete diastereoselectivity for the 2,5-*syn*diastereoisomers. Although this stereochemical relationship could not be discerned from the ^1^H NMR spectra of **14**due to peak broadening caused by amide rotamers, a combination of further elaboration and X-ray crystallographic analysis confirmed the assignment.

![The sulfone-mediated synthesis of 2,5-*syn*disubstituted pyrrolidines *via*a 5-*endo*-trig cyclisation](1860-5397-3-39-i3){#C3}

Deprotection of simple benzoyl-protected pyrrolidines **14a**and **14b**could be achieved by acid hydrolysis (Scheme [4](#C4){ref-type="fig"} and Table [1](#T1){ref-type="table"}). However, as with the tosyl-based methodology, such reaction conditions were incompatible with the terminal alkene-substituted pyrrolidine **14c**. Therefore alternative deprotection conditions were investigated. Attempted base-mediated hydrolysis led to formation of the *N*-benzoylaminosulfone **11**, presumably by a sequence involving ring-opening by elimination, hydration of the electron-deficient alkenyl sulfone double bond and retro-aldol-like fragmentation. Reductive deprotection proved to be a more fruitful avenue of study. After considerable optimisation it was found that treatment of the *N*-benzoylpyrrolidines with Super-Hydride^®^\[[@B18]\] gave the free amines **15**, whilst the use of DIBAL in THF furnished the benzyl-protected pyrrolidines **16**in good yield (Scheme [4](#C4){ref-type="fig"} and Table [1](#T1){ref-type="table"}).

###### 

Deprotection of *N*-benzoylpyrrolidines

  **Pyrrolidine**   **R**^1^     **R**^2^               **Reagent**        **R**^3^   **Product**   **Yield (%)**
  ----------------- ------------ ---------------------- ------------------ ---------- ------------- ---------------
  **14a**           *i*Pr        C~6~H~13~              HCl                H          **15a**       69
  **14b**           CH~2~*i*Pr   C~6~H~13~              HCl                H          **15b**       60
  **14a**           *i*Pr        C~6~H~13~              Super-Hydride^®^   H          **15a**       69
  **14c**           *i*Pr        (CH~2~)~3~CH = CH~2~   Super-Hydride^®^   H          **15c**       57
  **14c**           *i*Pr        (CH~2~)~3~CH = CH~2~   DIBAL              Bn         **16c**       70
  **14d**           Bn           Me                     DIBAL              Bn         **16d**       67
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With the chemistry now in place to undertake the synthesis of (+)-monomorine I, the initial target, pyrrolidine **22**, was prepared. Commercially available D-norleucine was reduced to the amino alcohol **17**. \[[@B19]\] This was then converted into the benzoyl-protected aminosulfone **20***via*the diphenylphosphinylaziridine **18,**which was ring-opened to give **19**, followed by protecting group exchange (Scheme [5](#C5){ref-type="fig"}). Formation of the dianion of **20**by exposure to two equivalents of *n*-butyllithium, followed by reaction with hex-5-enal and *in situ*trapping of the intermediate alkoxides gave the ester **21**as predominantly one diastereoisomer. Finally, one-pot elimination-cyclisation, promoted by two equivalents of potassium *tert*-butoxide, furnished the 2,5-*syn*-pyrrolidine **22**as a single diastereoisomer. Concurrently with the synthesis of **22**, the *iso*propyl model system, **14c**, was prepared using analogous chemistry.
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Deprotection of **22**and **14c**was readily achieved with Super-Hydride^®^to give the free amines **23**and **15c**, which were subjected to mercury-mediated hydroamination (Scheme [6](#C6){ref-type="fig"} &[7](#C7){ref-type="fig"}). \[[@B20]\] Cyclisation of **23**proceeded in good yield to give a 9:4 mixture of two indolizidines, epimeric at the C-5 methyl group **24-*anti***and **24-*syn***(Scheme [6](#C6){ref-type="fig"}). Cyclisation of the *iso*propyl analogue **15**proceeded with improved stereoselectivity to give a 5:1 mixture of epimeric indolizidines **26-*anti***and **26-*syn***(Scheme [7](#C7){ref-type="fig"}). Presumably, the increased steric bulk of the *iso*propyl group is responsible for the higher *anti*-selectivity. Assignment of the relative stereochemistry of the epimeric pairs proved problematic due to difficulties encountered during separation, and the presence of overlapping signals in the ^1^H NMR spectrum. Finally, a combination of X-ray diffraction analysis and comparison of the ^1^H NMR showed that the major diastereoisomer in each case was the undesired C-5 epimer, with the methyl group residing in the axial position. Naturally, we had assumed that the diastereoisomer in which all the substituents adopted a pseudo-equatorial orientation would have been formed preferentially. Yet inspection of the possible transition states for the cyclisation **25***vs*. **27**reveals that the axial methyl may be favoured so as to minimize the strain associated with the eclipse of the C-3 and C-5 substituents (Scheme [7](#C7){ref-type="fig"}). Branching of the *iso*propyl substituent would cause greater interaction than the butyl group, and therefore would lead to an increase in selectivity.
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The findings described above dictated that an alternative cyclisation strategy be investigated. It was anticipated that intramolecular reductive amination of a pendant methyl ketone would furnish the correct diastereoisomer, because the hydride source would be expected to approach the iminium ion from the less sterically demanding face, with the C-9 stereocentre being the controlling factor. \[[@B21]\] Both the benzoyl protecting group and the free amine were deemed incompatible with such a strategy. Therefore, **22**and **14c**were converted into the benzyl-protected pyrrolidines **28**and **16c**respectively by partial reduction with DIBAL-H (Schemes [8](#C8){ref-type="fig"} &[9](#C9){ref-type="fig"}). Wacker oxidation\[[@B22]\] of the *iso*propyl model compound **16c**gave the desired methyl ketone, which was subjected to transfer hydrogenation. \[[@B23]\] The latter reaction precipitated a reaction cascade commencing with deprotection of the *N*-benzylpyrrolidine followed by intramolecular reductive amination to give the desired indolizidine **26-*syn***as a single diastereoisomer in 18% yield for the two steps. Whilst the yield of this unoptimised reaction was not satisfactory, we were pleased to observe that only the desired diastereoisomer was formed.
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Oxidation of the terminal alkene of **28**under Wacker conditions proved highly capricious and was ultimately abandoned in favour of a more reliable oxymercuration protocol. \[[@B24]\] Under these conditions the methyl ketone **29**was isolated in 70% yield (Scheme [9](#C9){ref-type="fig"}). Catalytic transfer hydrogenation led to sequential debenzylation and intramolecular reductive amination to furnish **24-*syn***as a single diastereoisomer in excellent yield. Desulfonylation was achieved by brief exposure of **24-*syn***to sodium naphthalenide in THF to furnish (+)-monomorine I, which showed ^1^H and ^13^C NMR, IR, mass spectral and optical rotation characteristics in agreement with published values. \[[@B25]\] Short reaction times were found to be crucial to the success of this reaction.

In summary, we have developed a highly stereoselective 5-*endo*-trig cyclisation reaction that facilitates the preparation of 2,5-*syn*disubstituted pyrrolidines. We have used this transformation as the key step in the synthesis of the indolizidine alkaloid, (+)-monomorine I. The synthesis was achieved in nine steps from the readily available aziridine **18**, and compares favourably with other total syntheses in the literature.

See Additional File [1](#S1){ref-type="supplementary-material"} for full experimental data.
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The enantiospecific synthesis of (+)-monomorine I using a 5-*endo*-trig cyclisation strategy: full experimental data. Full preparative details of all compounds prepared are reported, together with their spectroscopic data.
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